News Releases
 Print Email

Syngenta Biotechnology, Inc. Recognized for Exemplary Workplace Safety

6/24/2010

  • Syngenta Biotechnology, Inc. (SBI) receives two key safety awards from the North Carolina Department of Labor’s Occupational Safety & Health Administration (OSHA)
  • Recognized for exemplary safety record and one million hours without an OSHA recordable incident
RESEARCH TRIANGLE PARK, N.C., USA — Syngenta Biotechnology, Inc., (SBI) recently received two distinguished Occupational Safety & Health Administration (OSHA) awards from the N.C. Department of Labor. The company, which is based in Research Triangle Park, N.C. and focuses on plant biotechnology and crop genetics, was formally recognized for achieving both the annual safety award and the million-hour safety award at a regional banquet earlier this month.
 
SBI received the annual gold level award for achieving an exemplary safety record in 2009, a qualification achieved by less than one percent of North Carolina companies. SBI also received recognition for reaching one million employee hours without an OSHA recordable incident, a feat accomplished by only one in 3,300 companies in a given year.
 
“We are very proud of these awards and would like to thank the N.C. Department of Labor for this recognition,” said Bill Hlavac, head of site operations for SBI. “We strive to create a safe and healthy work environment, and as our company continues to grow, we hope the community continues to see SBI as a responsible corporate citizen and a great place to work.”
 
The N.C. Department of Labor safety awards program recognizes private and public companies throughout the state that achieve and maintain good safety records. To qualify for an annual safety award, a company must have had no fatalities at the site or location for which the award was given and have maintained an incidence rate at least 50 percent below average for its industry. 
 
The gold level safety award, which factors in days away from work, restricted activity and job transfer as a result of workplace incident, is the top-level award for annual safety. Million-hour safety awards recognize companies that clock one million employee hours without incidence of injury or illness involving days away from work.
 
SBI was founded with the principle of delivering innovation in plant gene technology and serves as the key North American location for plant biotechnology research and development for Syngenta. The company, which employs approximately 400 people, recently moved into a new 100,000 square foot facility at Keystone Office Park as part of a long-term growth plan that will supplement the existing Cornwallis Drive facility.
 
Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
 
 
###
 
Media contacts:
Paul Minehart
Syngenta Corporation 
paul.minehart@syngenta.com
 
Casey Novak
Gibbs & Soell, Inc. Public Relations
cnovak@gibbs-soell.com, 919-870-5718
 
Related Links:
 
The Syngenta logo is a registered trademark of a Syngenta Group Company.
 
Cautionary Statement Regarding Forward-Looking Statements
 
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.